NIOX Group PLC (LON:NIOX)

57.40p+3.99%
Spriggl Score: Strong— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict

Dominant global breathing-test device franchise with strong cash generation; premium valuation hinges on new product uptake.

Sign up free to read the full investment thesis, bull case, bear case and what to watch.

About NIOX Group PLC

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, se

Sector:
Healthcare
Industry:
Medical Devices
Market Cap:
£237.4M

Recent dividends

  • 21 May 20261.55p
  • 15 May 20251.25p
  • 23 May 20241.00p

Get the full Spriggl analysis — free

A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across NIOX Group PLC and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.

Start free